SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000886163-17-000121
Filing Date
2017-11-02
Accepted
2017-11-01 17:49:29
Documents
4
Period of Report
2017-11-01

Document Format Files

Seq Description Document Type Size
1 10-Q/A a10-qaforlgndx6301110q.htm 10-Q/A 29711
2 EXHIBIT 10.27 lgndexhibit1027.htm EX-10.27 376554
3 EXHIBIT 31.3 lgndexhibit313.htm EX-31.3 4556
4 EXHIBIT 31.4 lgndexhibit314.htm EX-31.4 4551
  Complete submission text file 0000886163-17-000121.txt   416412
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-33093 | Film No.: 171170112
SIC: 2834 Pharmaceutical Preparations